Xeris Biopharma (XERS) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.06
-0.04
-0.01
0.01

Details

Expected EPS
-0.002743
Actual EPS
0.01
Surprise EPS
0.01
Surprise Percent
+464.56%

Description

Xeris Biopharma (XERS) has reported earnings of 0.01 per share for Q2 2026.

0 Comments

Share your thoughts